News

The project is undertaken jointly by NCBS, Stanford University and Technical University of Denmark. VLife Sciences Technologies said that the project involves studying coiled coil interactions in proteins

BioClinica said that with this acquisition, it has enhanced its ability to serve customers throughout the clinical research process with technologies that include improved efficiencies by reducing study

Keyrus Biopharma has gained flexibility in designing clinical trials and managing data collection, as well as increased scalability to support business expansion, with Oracle Clinical. The solution provides

Discovered and developed by Eisai, Eritoran is believed to block activation of toll-like receptor 4 (TLR4). TLR4 is part of the innate immune system and, when it is

Access Pharmaceuticals said that MuGard is ready-to-use mucoadhesive oral wound rinse and coating for the management of oral mucositis, a debilitating side effect of many anticancer treatments. As

As per the agreement, the companies are expected to study short interfering RNA (siRNA) complexed to PTD-DRBD, with the ultimate goal of developing drugs using this technology. Hans

The system is compact (1/3 of a classic granulation line inclusive of a Tablet Press) and has a modular construction allowing it to fit perfectly into any R&D

BioAlliance Pharma said that, with this approval to a total of 26 European countries for Loramyc and the recent Setofilm approval in 16 European countries, it is building

The new treatment can be used on large areas of skin, including the full face or balding scalp on a convenient, 6-week dosing cycle. Graceway Pharma said that